Authors:
Boehm, MF
Fitzgerald, P
Zou, AH
Elgort, MG
Bischoff, ED
Mere, L
Mais, DE
Bissonnette, RP
Heyman, RA
Nadzan, AM
Reichman, M
Allegretto, EA
Citation: Mf. Boehm et al., Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D-3, CHEM BIOL, 6(5), 1999, pp. 265-275
Authors:
Zou, AH
Marschke, KB
Arnold, KE
Berger, EM
Fitzgerald, P
Mais, DE
Allegretto, EA
Citation: Ah. Zou et al., Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen, MOL ENDOCR, 13(3), 1999, pp. 418-430
Authors:
Zhi, L
Tegley, CM
Marschke, KB
Mais, DE
Jones, TK
Citation: L. Zhi et al., 5-aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: Effect of A-ring modification, J MED CHEM, 42(8), 1999, pp. 1466-1472
Authors:
Wagner, BL
Pollio, G
Giangrande, P
Webster, JC
Breslin, M
Mais, DE
Cook, CE
Vedeckis, WV
Cidlowski, JA
McDonnell, DP
Citation: Bl. Wagner et al., The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: Implicationsfor the development of dissociated antiprogestins, ENDOCRINOL, 140(3), 1999, pp. 1449-1458
Authors:
Zhi, L
Tegley, CM
Edwards, JP
West, SJ
Marschke, KB
Gottardis, MM
Mais, DE
Jones, TK
Citation: L. Zhi et al., 5-alkyl 1,2-dihydrochromeno[3,4-f]quinolines: A novel class of nonsteroidal progesterone receptor modulators, BIOORG MED, 8(23), 1998, pp. 3365-3370
Authors:
Takeuchi, K
Kohn, TJ
True, TA
Mais, DE
Wikel, JH
Utterback, BG
Wyss, VL
Jakubowski, JA
Citation: K. Takeuchi et al., Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 3. Synthesis and biological activities of oxazolecarboxamide-substituted omega-phenyl-omega-(3-pyridyl)alkenoic acid derivatives and related compounds, J MED CHEM, 41(27), 1998, pp. 5362-5374